Stock Research: BioLife Slutn

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

BioLife Slutn

NasdaqCM:BLFS US09062W2044
25
  • Value
    51
  • Growth
    89
  • Safety
    Safety
    22
  • Combined
    58
  • Sentiment
    20
  • 360° View
    360° View
    25
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

BioLife Solutions, Inc. develops and supplies cell processing tools and services for the cell and gene therapy (CGT) market. The company operates in the cell and gene therapy market, offering solutions for cell preservation and processing. Its products include CryoStor freeze media, Sexton cell processing product line, CellSeal cryogenic vials, and ThawSTAR thawing devices. In the last fiscal year, the company had a market cap of $1,000 million, profits of $54 million, and revenue of $82 million with 159 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 25 (better than 25% compared with alternatives), overall professional sentiment and financial characteristics for the stock BioLife Slutn are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for BioLife Slutn. The consolidated Growth Rank has a good rank of 89, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 89% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 51 which means that the company has a financing structure that is safer than 51% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 22 which means that the share price of BioLife Slutn is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 78% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 20, which means that professional investors are more pessimistic about the stock than for 80% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 20 44 63
Growth
89 91 27 71
Safety
Safety
51 20 56 56
Sentiment
20 82 33 17
360° View
360° View
25 71 81 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
79 84 61 23
Opinions Change
13 50 50 50
Pro Holdings
n/a 63 32 75
Market Pulse
45 40 36 16
Sentiment
20 82 33 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
22 20 44 63
Growth
89 91 27 71
Safety Safety
51 20 56 56
Combined
58 33 72 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
58 58 58 6
Price vs. Earnings (P/E)
7 11 38 62
Price vs. Book (P/B)
47 40 58 79
Dividend Yield
1 1 1 1
Value
22 20 44 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
72 4 10 71
Profit Growth
52 90 90 9
Capital Growth
98 95 9 91
Stock Returns
61 87 47 53
Growth
89 91 27 71
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
75 60 53 62
Refinancing
41 18 39 31
Liquidity
24 14 28 28
Safety Safety
51 20 56 56

Similar Stocks

Discover high‑ranked alternatives to BioLife Slutn and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.